ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions
- Cervical Adenocarcinoma
- Cervical Adenosquamous Carcinoma
- Cervical Small Cell Carcinoma
- Cervical Squamous Cell Carcinoma
- Recurrent Cervical Carcinoma
Interventions
- DRUG: Paclitaxel Albumin-Stabilized Nanoparticle Formulation
- OTHER: Laboratory Biomarker Analysis
Sponsor
Gynecologic Oncology Group
Collaborators